These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7578402)

  • 1. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A phase I study.
    Hum Gene Ther; 1994 Aug; 5(8):1019-57. PubMed ID: 7948139
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
    Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is gene therapy in cystic fibrosis a realistic expectation?
    McElvaney NG
    Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.
    Crystal RG; McElvaney NG; Rosenfeld MA; Chu CS; Mastrangeli A; Hay JG; Brody SL; Jaffe HA; Eissa NT; Danel C
    Nat Genet; 1994 Sep; 8(1):42-51. PubMed ID: 7527271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus.
    Welsh MJ; Zabner J; Graham SM; Smith AE; Moscicki R; Wadsworth S
    Hum Gene Ther; 1995 Feb; 6(2):205-18. PubMed ID: 7537540
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenovirus-mediated in vivo gene transfer.
    Brody SL; Crystal RG
    Ann N Y Acad Sci; 1994 May; 716():90-101; discussion 101-3. PubMed ID: 7517653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium.
    Welsh MJ; Smith AE; Zabner J; Rich DP; Graham SM; Gregory RJ; Pratt BM; Moscicki RA
    Hum Gene Ther; 1994 Feb; 5(2):209-19. PubMed ID: 7514450
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
    Zabner J; Wadsworth SC; Smith AE; Welsh MJ
    Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.
    Perricone MA; Morris JE; Pavelka K; Plog MS; O'Sullivan BP; Joseph PM; Dorkin H; Lapey A; Balfour R; Meeker DP; Smith AE; Wadsworth SC; St George JA
    Hum Gene Ther; 2001 Jul; 12(11):1383-94. PubMed ID: 11485630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.